iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionNtv Asset Management Llc
Latest Disclosed Ownership54,464 shares
Latest Disclosed Value $ 9,196,260
Ntv Asset Management Llc reports 0.43% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 28, 2026 - Ntv Asset Management Llc filed a 13F-HR form disclosing ownership of 54,464 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $9,196,260 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 54,233 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.43% during the quarter. The current value of the position is $7,137,507 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F iShares TR ISHARES BIOTECH 464287556 54,464 231 0.43 9,196 0.48 1.0109
2026-01-20 2025-12-31 13F iShares TR ISHARES BIOTECH 464287556 54,233 825 1.54 9,153 18.70 0.9693
2025-10-21 2025-09-30 13F iShares TR ISHARES BIOTECH 464287556 53,408 440 0.83 7,711 15.07 0.8406
2025-07-21 2025-06-30 13F iShares TR ISHARES BIOTECH 464287556 52,968 -1,465 -2.69 6,701 -3.75 0.8008
2025-04-30 2025-03-31 13F iShares TR ISHARES BIOTECH 464287556 54,433 125 0.23 6,962 -3.05 0.9273
2025-01-31 2024-12-31 13F iShares TR ISHARES BIOTECH 464287556 54,308 -620 -1.13 7,180 -10.22 0.9468
2024-10-31 2024-09-30 13F iShares TR ISHARES BIOTECH 464287556 54,928 1,640 3.08 7,998 9.34 1.0694
2024-07-31 2024-06-30 13F iShares TR ISHARES BIOTECH 464287556 53,288 -318 -0.59 7,314 -0.56 1.0469
2024-05-07 2024-03-31 13F iShares Tr ISHARES BIOTECH 464287556 53,606 610 1.15 7,356 2.17 1.1210
2024-02-06 2023-12-31 13F iShares TR ISHARES BIOTECH 464287556 52,996 -2,404 -4.34 7,199 6.27 1.2127
2023-11-06 2023-09-30 13F iShares TR ISHARES BIOTECH 464287556 55,400 -1,504 -2.64 6,775 -6.23 1.2273
2023-08-02 2023-06-30 13F iShares TR ISHARES BIOTECH 464287556 56,904 -974 -1.68 7,224 -3.36 1.2598
2023-05-05 2023-03-31 13F iShares TR ISHARES BIOTECH 464287556 57,878 125 0.22 7,476 -1.41 1.3908
2023-02-08 2022-12-31 13F iShares TR ISHARES BIOTECH 464287556 57,753 1,505 2.68 7,582 15.25 1.4894
2022-11-07 2022-09-30 13F iShares TR ISHARES BIOTECH 464287556 56,248 176 0.31 6,579 -0.26 1.3837
2022-07-28 2022-06-30 13F iShares TR ISHARES BIOTECH 464287556 56,072 391 0.70 6,596 -9.08 1.2900
2022-05-06 2022-03-31 13F iShares TR ISHARES BIOTECH 464287556 55,681 -249 -0.45 7,255 -15.01 1.2165
2022-02-04 2021-12-31 13F iShares TR ISHARES BIOTECH 464287556 55,930 -100 -0.18 8,536 -5.77 1.4164
2021-11-10 2021-09-30 13F iShares TR ISHARES BIOTECH 464287556 56,030 -84 -0.15 9,059 -1.35 1.5728
2021-08-09 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 56,114 -10 -0.02 9,183 8.67 1.6239
2021-05-10 2021-03-31 13F Ishares TR NASDAQ BIOTECH 464287556 56,124 -605 -1.07 8,450 -1.68 1.5636
2021-02-05 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 56,729 -180 -0.32 8,594 11.52 1.7288
2020-10-29 2020-09-30 13F iShares TR NASDAQ BIOTECH 464287556 56,909 -349 -0.61 7,706 -1.55 1.8300
2020-08-07 2020-06-30 13F Ishares TR NASDAQ Biotech 464287556 57,258 -180 -0.31 7,827 26.49 2.0258
2020-05-06 2020-03-31 13F Ishares TR NASDAQ Biotech 464287556 57,438 -1,094 -1.87 6,188 -12.28 2.0327
2020-01-30 2019-12-31 13F Ishares TR NASDAQ Bitotech 464287556 58,532 285 0.49 7,054 21.70 1.7970
2019-11-04 2019-09-30 13F Ishares TR NASDAQ Biotech 464287556 58,247 -3,250 -5.28 5,796 -13.61 1.6500
2019-07-29 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 61,497 -1,469 -2.33 6,709 -4.70 1.9254
2019-04-29 2019-03-31 13F Ishares TR NASDAQ BIOTECH 464287556 62,966 75 0.12 7,040 16.08 2.0092
2019-01-28 2018-12-31 13F Ishares TR NASDAQ BIOTECH 464287556 62,891 -1,155 -1.80 6,065 -22.34 1.9652
2018-11-08 2018-09-30 13F Ishares Tr NASDAQ Biotech 464287556 64,046 1,813 2.91 7,810 14.28 2.1096
2018-08-06 2018-06-30 13F Ishares Tr NASDAQ BIOTECH 464287556 62,233 345 0.56 6,834 3.45 1.9243
2018-05-04 2018-03-31 13F Ishares Tr NASDAQ Biotech 464287556 61,888 3,585 6.15 6,606 6.12 1.8752
2018-02-06 2017-12-31 13F Ishares Tr NASDAQ Biotech 464287556 58,303 38,769 198.47 6,225 -4.47 1.7331
2017-11-06 2017-09-30 13F Ishares TR NASDAQ Biotech 464287556 19,534 959 5.16 6,516 13.14 1.8897
2017-08-08 2017-06-30 13F Ishares Tr NADSQ Biotec ETF 464287556 18,575 2,617 16.40 5,759 23.06 1.7548
2017-05-03 2017-03-31 13F Ishares Tr NADSQ Biotec ETF 464287556 15,958 1,375 9.43 4,680 20.93 1.4832
2017-02-14 2016-12-31 13F Ishares Tr NADSQ Biotec ETF 464287556 14,583 578 4.13 3,870 -4.54 1.3359
2016-11-08 2016-09-30 13F Ishares Tr NADSQ Biotec ETF 464287556 14,005 0 0.00 4,054 12.49 1.4615
2016-08-08 2016-06-30 13F Ishares Tr NADSQ Biotec ETF 464287556 14,005 3,925 38.94 3,604 37.09 1.3653
2016-05-02 2016-03-31 13F Ishares Tr NADSQ Biotec ETF 464287556 10,080 0 0.00 2,629 -22.90 1.0092
2016-02-02 2015-12-31 13F Ishares Tr NADSQ Biotec ETF 464287556 10,080 -2,215 -18.02 3,410 -8.55 1.3455
2015-11-05 2015-09-30 13F Ishares Tr NADSQ Biotec ETF 464287556 12,295 -25 -0.20 3,729 -17.95 1.2116
2015-08-05 2015-06-30 13F Ishares Tr NADSQ Biotec ETF 464287556 12,320 -18 -0.15 4,545 7.27 1.3331
2015-05-05 2015-03-31 13F Ishares Tr NADSQ Biotec ETF 464287556 12,338 -6,950 -36.03 4,237 -27.59 1.2616
2015-02-23 2014-12-31 13F Ishares Tr NADSQ Biotec ETF 464287556 19,288 -550 -2.77 5,851 7.79 1.7323
2014-10-31 2014-09-30 13F Ishares Tr NADSQ Biotec ETF 464287556 19,838 -104 -0.52 5,428 5.91 1.6459
2014-07-31 2014-06-30 13F Ishares NADSQ Biotec ETF 464287556 19,942 -440 -2.16 5,125 6.37 1.5543
2014-05-05 2014-03-31 13F Ishares NADSQ Biotec ETF 464287556 20,382 -35 -0.17 4,818 3.93 1.5443
2014-02-11 2013-12-31 13F Ishares NADSQ Biotec ETF 464287556 20,417 -25 -0.12 4,636 8.22 1.5732
2013-11-07 2013-09-30 13F Ishares NADSQ Biotec ETF 464287556 20,442 0 0.00 4,284 20.54 1.5016
2013-08-08 2013-06-30 13F Ishares Tr NASDQ Bio Indx 464287556 20,442 20,442 3,554 1.2906
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.